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Abstract
The usefulness of two quantitative real-time PCR assays (qrt-PCRmip targeting Legionella pneumophila, and qrt-PCR16S targeting all Legio-
nella species) performed on lower respiratory tract (LRT) samples for diagnostic and prognostic purposes in 311 patients hospitalized for
community-acquired pneumonia (CAP) in Rhoˆne-Alpes (France) was evaluated. The Now Legionella urinary antigen test (UAT) from Binax
(Portland, ME, USA) was used as a reference test. Samples were divided into two groups. Group A included 255 CAP patients admitted
to Chambery hospital in 2005 and 2006. The Now Legionella UAT was positive in 14 patients. Sensitivities, specificities, positive predictive
and negative predictive values for both qrt-PCR tests were 63.6, 98.7, 77.7 and 97.4%, respectively. Group B included 56 consecutive legi-
onellosis patients diagnosed during a 4-year period (2003–2006) at the Grenoble University Hospital. The qrt-PCR16S and qrt-PCRmip
displayed a sensitivity of 82.14 and 80.4%, respectively. Among the 70 legionellosis cases, L. pneumophila serogroup 1 was isolated in 15;
qrt-PCRmip was positive in another 36, suggesting L. pneumophila infection, whereas the Legionella species involved could not be deter-
mined in the remaining 19 cases. The Legionella burden in LRT samples at the time of admission was determined in 46 patients using
qrt-PCR16S tests, 44 for qrt-PCR mip groups A and B patients. It varied from 1.9 to 8.35 log10 DNA copies/mL of LRT sample for
qrt-PCR16S and from 1.9 to 8.11 log10 DNA copies/mL of sample for qrt-PCRmip. High bacterial loads in LRT samples at hospital admission
were significantly associated with higher Fine classes, the need for hospitalization in an intensive care unit and for prolonged hospitalization.
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Introduction
Legionellosis is a pneumonia caused by inhalation of Legionella
species-contaminated aerosols [1]. It is responsible for 2–15%
of all community-acquired pneumonias (CAP) requiring hospi-
tal admission [2]. Of the 50 species and 72 serogroups
belonging to the genus Legionella, L. pneumophila serogroup
one (sg1) is responsible for at least 80% of human infections
[1–3]. Mortality rates of 10–15% are usually reported [1,2]
but may be higher in immunocompromised patients.
The severity of legionellosis depends primarily on the
immune status of the patient and the speed of diagnosis and
administration of an appropriate antibiotic therapy [1,4].
Culture-based diagnosis of legionellosis remains fastidious
and its sensitivity is poor [1]. Direct fluorescence antibody
staining of Legionella spp. in respiratory samples is considered
unreliable [1,2,5,6]. Serological diagnosis lacks both sensitivity
and specificity [5,7], and only provides a retrospective diag-
nosis. In recent years, L. pneumophila urinary antigen tests
(UATs) have become reference tests allowing rapid legionel-
losis diagnosis [5,8–14]. These tests are considered highly
sensitive, although they may be negative at the early stage of
legionellosis, and highly specific, although urinary antigens
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may persist for months in some patients [12,15]. However,
these tests detect primarily L. pneumophila sg1 antigens and
are much less sensitive in detecting other Legionella sero-
groups or species [5,8,12]. PCR-based techniques have been
developed as rapid diagnostic tools, potentially allowing
amplification of DNA from all Legionella species and sero-
groups [5,16–27], but these tests are poorly standardized.
In the present study, taking the Now Legionella UAT as a
reference test, we evaluated the relative sensitivities and
specificities of two qrt-PCR assays for legionellosis diagnosis
in CAP patients requiring hospitalization. Additionally, in a
subset of legionellosis patients, we quantified L. pneumophila
DNA burden in lower respiratory tract (LRT) samples at
hospital admission and tentatively correlated bacterial loads
with disease severity.
Materials and Methods
Patients
CAP patient inclusion criteria were as follows: patients
> 18 years old, admitted to hospital with clinical and radio-
logical findings suggestive of pneumonia (fever, cough, expec-
toration, dyspnoea, thoracic pain, new or progressive
infiltrate on chest X-ray), in whom the infection occurred
outside the hospital setting. The Fine class, a pneumonia
severity index [28], was determined at the time of admission.
Patients were considered legionellosis cases when clinical
signs compatible with CAP were present, and a Legionella
strain was grown in culture and/or a Now Legionella UAT
was positive.
Patients were divided into two groups. Group A included
consecutive patients hospitalized for CAP from November
2004 to March 2006 at the General Hospital of Chambery,
France. Group B included consecutive legionellosis cases,
hospitalized at the University Hospital of Grenoble during a
3-year period (2003–2006).
Microbiological investigations
Usual microbiological investigations were carried out at hos-
pital admission: two sets of blood cultures (Bactec 9240;
Becton Dickinson, Grenoble, France); culture of LRT samples
[i.e. bronchial aspirations and/or bronchoalveolar lavage
(BAL) specimens and/or sputum samples], including Legionella
culture on buffered charcoal yeast extract medium supple-
mented with a-ketoglutarate (Oxoid, Wesel, Germany); an
indirect immunofluorescence assay (IFA) for detection of
serum antibodies directed against L. pneumophila sgs1–6
(Meridian Diagnostics Inc., Cincinnati, OH, USA); the Now
Legionella UAT (Binax, Portland, ME, USA) performed on
urine samples 25-fold concentrated by selective ultrafiltration
(Minicon B15; Millipore Corp., Bedford, MA, USA). Addition-
ally, two Legionella qrt-PCR assays were performed on LRT
samples, either tested immediately after collection or frozen
at )80C for several days to 1 month before testing.
qrt-PCR assays
DNA was extracted from the patients’ LRT samples using
QIAamp DNA Mini kit (QIAGEN, Hilden, Germany). Two
qrt-PCR assays previously described in the literature [29],
which we had used to quantify Legionella spp. in water sam-
ples [30], were used. Analytical sensitivities, specificities, and
quantification limits of these techniques have been previously
described [29,30]. The qrt-PCR16S amplifies a 386-bp
portion of 16S ribosomal RNA-encoding genes of all Legionella
species [29,30]. The qrt-PCRmip amplifies a 186-bp portion of
the mip (macrophage internalization potentiator) gene of all
serogroups of L. pneumophila [29,30]. Primers, probes and
amplification protocols were as previously described [30],
and results obtained with the Light Cycler 2.0 instrument
(Roche, Meylan, France). A 374-bp internal inhibitor control
(3000 copies per reaction) was used in all experiments [30].
Mip and 16SrRNA gene amplification and sequencing
In patients with positive qrt-PCR tests but negative cultures,
we attempted to amplify and sequence nearly complete mip
and 16S rRNA genes directly from LRT samples, in order to
identify the Legionella species involved. PCR amplification was
performed using the mip gene primers and the procedure
previously reported by Ratcliff et al. [31] and Stolhaugh et al.
[32] and using the following primers for the 16SrRNA
gene: Lg16SFw (5¢-TTAACACATGCAAGTCGAACGG-3¢)
and Lg16SRv (5¢-ACCGGAAATTCCACTACCCT-3¢).
Statistical analysis
Using qrt-PCR assays, we evaluated the bacterial burden in
LRT samples at the time of admission, and tentatively corre-
lated this biological marker with age (<60 or >60 years), the
Fine class at hospital admission, the need for hospitalization
in an intensive care unit (ICU), and duration of hospitaliza-
tion (1–14 days vs. >14 days), using the two-tailed Student’s
t-test at the 95% confidence limit.
Results
Group A included 255 CAP patients, with a Fine class of
2 for 31 patients, 3 for 39 patients, 4 for 61 patients, 5
for 30 patients, and an undetermined Fine class for 94
patients.
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A blood culture was positive in 14 (5.5%) cases, with
isolation of Streptococcus pneumoniae in nine cases, Escherichia
coli in two cases, and S. pyogenes, Klebsiella pneumoniae or
Pseudomonas aeruginosa in one case each. In these patients,
Legionella cultures, the Now Legionella UAT and the qrt-PCR
tests were all negative.
A Now Legionella UAT was positive in 14 of 220 patients
tested (6.36%) (Table 1), of whom only seven cases gave
positive qrt-PCR tests. Legionella cultures from LRT samples
were negative in all 199 patients tested. A single positive IFA
test (IgG titre ‡256) was found in eight patients, including
two with a positive Now Legionella UAT and positive
qrt-PCR tests, one with a positive Now Legionella UAT but
negative qrt-PCR tests, and five with negative Now Legionella
UAT and qrt-PCR tests. The qrt-PCR tests were positive in
nine of 195 patients tested (4.61%), including seven patients
with a positive Now Legionella UAT and two patients with a
negative test. These two patients were considered to be
non-legionellosis cases because both Legionella culture and
UAT were negative. They presented with mild disease and
made a rapid recovery under ciprofloxacin therapy. They
had negative acute-phase serological tests. A convalescent
phase-serum was not available. We could not amplify the
whole Legionella mip and 16S rRNA genes from LRT samples.
When considering the 165 patients for whom both the
Now Legionella UAT and qrt-PCR test results were available,
and taking the former test as a reference, the results of both
qrt-PCR16S and qrt-PCRmip tests combined gave relative
sensitivities, specificities, positive predictive and negative pre-
dictive values of 63.6% (95% CI 63.1–64.2), 98.7% (95% CI
98.6–98.8), 77.7% (95% CI 77.2–78.2) and 97.4% (95% CI
97.2–97.6), respectively.
Group B included 56 legionellosis patients, with a Fine
class of 2 for four patients, 3 for 13 patients, 4 for six
patients, 5 for ten patients, and the Fine class was undeter-
mined for 23 patients. Blood cultures remained sterile for
these 56 patients. LRT samples taken from 52 patients
yielded a L. pneumophila sg1 strain in 15 cases (28.8% sensi-
tivity) (Table 1). All 15 cases gave a positive qrt-PCR16S test,
and 14 gave a positive qrt-PCRmip test (qrt-PCRmip was not
done in the remaining patient). The qrt-PCR16S and
qrt-PCRmip displayed sensitivities of 82.1 and 80.4%, respec-
tively (Table 1).
We were able to determine a L. pneumophila DNA burden
in LRT samples at the time of admission in 46 cases using
the qrt-PCR16S test and in 44 cases using the qrt-PCRmip
test. The mean ± SD of log10 DNA copies/mL of LRT sample
were 6.70 ± 7.52 for qrt-PCR16S (range 1.9–8.35 log10 DNA
copies/mL), and 6.48 ± 7.29 for qrt-PCRmip (range 1.9–8.11
log10 DNA copies/mL). The bacterial load was >10
3 DNA
copies/mL of sample in 29 of 46 (63.0%) and 30 of 44
(68.2%) patients, as determined by the qrt-PCR16S and
qrt-PCRmip tests, respectively.
There was a linear relationship between bacterial loads
determined by both qrt-PCR16S and qrt-PCRmip (Fig. 1).
The mean ± SD of log10 DNA copies/mL of LRT sample was
higher in Legionella culture-positive patients (7.28 ± 7.81 for
qrt-PCR16S and 7.08 ± 7.59 for qrt-PCRmip) than in
culture-negative patients (4.18 ± 4.76 for qrt-PCR16S and
4.27 ± 4.81 for qrt-PCRmip), although the difference was
not statistically significant.
In a subset of 32 group B patients, for whom clinical and
epidemiological data were available, a high L. pneumophila
bacterial load in LRT samples at hospital admission was sig-
nificantly correlated with higher Fine classes (4 or 5 vs. 2 or
3) (p <0.01), with the need for admission to an ICU
(p <0.01) and with hospitalization >2 weeks (p 0.01), but not
with age (Fig. 2). Evidently, the first two criteria were corre-
lated since most patients with a Fine class of 4 or 5 on
TABLE 1. Laboratory results for legionellosis diagnosis in
group A and group B patients
Group A patients Positive/tested %
Result/tested when
Now AUT
Positive Negative
Now UATa 14/220 6.4
IFAa 8/220 3.6 3/14 5/206
Legionella culturea 0/199 0 0/11 0/188
qrt-PCR testsa 9/195 4.6 7/11 2/184
Group B patients
Now UATa 56/56 100
Legionella culturea 15/52 28.8
qrt-PCR 16Sa 46/56 82.1
qrt-PCR mipa 41/51 80.4
aNow UAT, Binax Now Legionella urinary antigen test; IFA, immunofluorescence
assay (positive if IgG titre >256); Legionella culture and qrt-PCR tests were per-
formed on patients’ lower respiratory tract samples.
log10 DNA copies /mL LRT sample
y = 0.9757x + 0.2117
R2 = 0.9593
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FIG. 1. Correlation between Legionella bacterial loads in lower respi-
ratory tract (LRT) samples from legionellosis patients as determined
by qrt-PCR16S and as determined by qrt-PCRmip.
CMI Maurin et al. Quantitative real-time PCR for legionellosis diagnosis 381
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 379–384
hospital admission (i.e. 11/16, 68.7%) were hospitalized in an
ICU.
Discussion
The sensitivity of the Now Legionella UAT in concentrated
urine samples has been evaluated and ranges from 69.6 to
97.2% for L. pneumophila sg1 infections [10,33,34]. In the
present work, sensitivities of the tested qrt-PCR assays were
lower than that of the Now Legionella UAT. Because the
Now Legionella UAT is considered highly specific [9,15,34],
false-positive results with this test may not account for this
difference. However, PCR inhibition could not explain such a
difference, as evidenced by amplification of the internal inhib-
itor control incorporated in each LRT sample. Freezing the
sputum samples for a prolonged period before qrt-PCR test-
ing may have induced partial bacterial DNA degradation.
Also, for the 14 patients of the study with a positive Now
Legionella UAT but negative qrt-PCR tests, only poor-quality
spontaneous sputum samples were available. Finally, we
found the quantification limit of both qrt-PCR tests to be
approximately 80 genome copies per mL of LRT sample, and
patients with lower DNA copy numbers may not have been
detected.
In two group A patients, both 16S rRNA gene and mip
qrt-PCR tests were positive, whereas the Now Legionella
UAT was negative. We were unable to confirm these two
cases by amplification and sequencing of the whole Legionella
mip and 16S rRNA genes. However, in both cases, clinical
and epidemiological circumstances were compatible with legi-
onellosis, and the patients were cured with fluoroquinolone
therapy. Although we considered these two patients to be
false-positive cases, they may instead be true legionellosis
cases.
Diagnosis of legionellosis cases due to non-L. pneumophila
species remains difficult, because these species are fastidious,
making them difficult to grow, and they are poorly detected
by Legionella UATs [5,8,12]. Thus, sensitivity levels of only
approximately 45% were reported for nosocomially acquired
legionellosis cases, for whom non-L. pneumophila species are
more frequently involved [12]. The use of the combination
of two qrt-PCR tests potentially allowed us to detect legio-
nellosis cases due to non-L. pneumophila species, which will
typically present with a positive qrt-PCR16S but a negative
qrt-PCRmip. Among the 70 patients of the study with a posi-
tive Now Legionella UAT, 15 were culture-confirmed L. pneu-
mophila sg1 infections, and 34 culture-negative cases were
probably infected with L. pneumophila because the
qrt-PCRmip test was positive. We could not determine the
Legionella species involved in the remaining 21 patients,
because Legionella culture and qrt-PCRmip test results were
negative or unavailable. We could not amplify the whole mip
or 16S rRNA genes from LRT samples, but since these tests
were performed at the end of the study we suspect that
bacterial DNA was partially degraded, precluding amplifica-
tion of large DNA fragments. However, none of the 311
CAP patients investigated presented with a positive
qrt-PCR16S but a negative qrt-PCRmip. Altogether, our
results indicate that Legionella species other than L. pneumo-
phila may be infrequently responsible for CAP.
The L. pneumophila DNA load in LRT samples at the time
of hospital admission was very high in most patients, which
contrasts with the frequent negativity of Legionella cultures.
This suggests predominance of the viable but non-cultivable
state of bacteria in the airways of infected patients [35].
Interestingly, in patients with multiple LRT specimens, bacte-
rial loads were significantly inferior (‡2 log inferior) in BAL
samples compared with sputum or bronchial aspiration
samples. The use of saline solution during BAL processing
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FIG. 2. Correlation of Legionella bacterial loads
in lower respiratory tract (LRT) samples from
legionellosis patients at the time of hospital
admission with patients’ age (<60 or ‡60
years), the Fine class (pneumonia severity ind-
ex), the need for hospitalization in an intensive
care unit (ICU), and duration of hospitalization
(1–14 days vs. >14 days). Open bars: qrt-PCR
16S quantification. Filled bars: qrt-PCR mip
quantification. Statistical analysis using two-
tailed Student’s t-test, at the 95% confidence
limit.
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may lower the sensitivity of DNA detection because of
respiratory sample dilution.
A high L. pneumophila DNA load in LRT samples may
reflect exposure to aerosols with high bacterial loads, infec-
tion with a highly virulent L. pneumophila strain and/or poor
immune response in the infected host. This biological marker
was significantly correlated with severity of disease, as
evidenced by a higher Fine class on admission and the need
for hospitalization in an ICU, and with prolonged hospitaliza-
tion (>2 weeks). Although more clinical data are needed, our
study suggests that determining L. pneumophila DNA load in
LRT samples may help clinicians to evaluate prognosis in legi-
onellosis patients.
In conclusion, qrt-PCR assays were useful for confirming
community-acquired legionellosis cases caused by L. pneumo-
phila, although they had lower sensitivity than the UAT. On
two occasions, however, qrt-PCR tests allowed detection of
L. pneumophila DNA, when the Now Legionella UAT was neg-
ative. The Legionella UATs and qrt-PCR assays should be
considered complementary in the diagnostic armamentarium
for legionellosis. The qrt-PCR assays were also useful for
predicting disease severity, which may be a true advantage of
these techniques over available diagnostic methods and
therefore warrant further evaluation.
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